Jan 13, 2022 / 01:15PM GMT
Tycho W. Peterson - JPMorgan Chase & Co, Research Division - Senior Analyst
Good morning, everybody. Welcome to Day 4 of the health care conference. I'm Tycho Peterson from the life science team. It's my pleasure to introduce our next company this morning, Quanterix.
Before I turn it over to Kevin, just a quick reminder. You can submit questions through the website.
And with that, let me turn it over to Kevin.
E. Kevin Hrusovsky - Quanterix Corporation - Chairman & CEO
Thanks very much, Tycho. I think this is the 20th time I've presented at JPMorgan, and I would encourage investors to look at the regulatory filings. We will be making some forward-looking statements.
Now to start off in this conference, it's been incredible the number of meetings we've had over the last 4 days. And we've tried to incorporate some of the top questions that we were seeing from our investor base into this agenda.
But starting off with our achievements in 2021. We have this symbiotic relationship between RUO research and diagnostics that
Quanterix Corp at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 13, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers